Impact of 18F-FDG PET/CT on the therapeutic management in the initial staging of the esophageal cancer

被引:0
作者
Pifarre-Montaner, P. [1 ]
Fernandez-Leon, A. [1 ]
de Juan, R. [1 ]
del Ama-Salvador, M. E. [2 ]
Galan, M. [3 ]
Gamez-Cenzano, C. [1 ]
Sans, M. [4 ]
机构
[1] Hosp Univ Bellvitge, Unidad PET, IDI, Barcelona, Spain
[2] Hosp Univ Bellvitge, Serv Radiol, IDI, Barcelona, Spain
[3] Hosp Univ Bellvitge, Med Oncol Serv, Barcelona, Spain
[4] Hosp Univ Bellvitge, Serv Cirugia Gen, Barcelona, Spain
来源
REVISTA ESPANOLA DE MEDICINA NUCLEAR | 2009年 / 28卷 / 03期
关键词
Positron emission tomography; F-18-FDG; Esophageal carcinoma; Computed tomography; PET/CT; POSITRON-EMISSION-TOMOGRAPHY; SQUAMOUS-CELL CARCINOMA; ESOPHAGOGASTRIC JUNCTION; COMPUTED-TOMOGRAPHY; STRATEGIES;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: The incidence of esophageal cancer has increased considerably over recent years, it now being the 6(th) most frequent cause of cancer-related death. Our study has aimed to compare the clinical value of PET/CT and CT scan in the initial staging of patients with esophageal cancer. Material and methods: Fifty nine patients (6 women) diagnosed of esophageal cancer were assessed retrospectively. All patients underwent diagnostic CT scan and PET/CT for initial staging within 3 to 15 days following clinical diagnosis. Results: PET/CT showed intracellular F-18-FDG entrapment having pathological significance in all the tumors (100%), signs of locoregional lymph node infiltration (N1) in 34 and a total of 19 lesions consistent with metastasis (M1) in 14 patients (23.72%). The CT scan detected malignancy in 57 patients (96.6%), abnormal lymph node in 32 patients and 17 N1 in 12 patients (20.33%). In three cases, CT- PET detected synchronous esophageal lesion in staging studies for other neoplastic processes (lung and ear-nose-throat). Conclusion: PET/CT showed a higher detection rate of primary malignant lesions, abnormal lymph nodes and distant metastases. A change in stage was only observed in two patients. (C) 2008 Elsevier Espana, S.L. and SEMN. All rights reserved.
引用
收藏
页码:101 / 105
页数:5
相关论文
共 26 条
  • [1] *AJCC, 2002, CANC STAG BOOK
  • [2] RADICAL LYMPH-NODE DISSECTION FOR CANCER OF THE THORACIC ESOPHAGUS
    AKIYAMA, H
    TSURUMARU, M
    UDAGAWA, H
    KAJIYAMA, Y
    [J]. ANNALS OF SURGERY, 1994, 220 (03) : 364 - 373
  • [3] The decision to operate: rote of integrated computed tomography positron emission tomography in staging oesophageal and oesophagogastric junction cancer by the multidisciplinary team
    Berrisford, Richard G.
    Wong, Wei-Lup
    Day, David
    Toy, Elizabeth
    Napier, Mark
    Mitchell, Keith
    Wajed, Saj
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2008, 33 (06) : 1112 - 1116
  • [4] Improvement in staging of esophageal cancer with the addition of positron emission tomography
    Block, MI
    Patterson, GA
    Sundaresan, RS
    Bailey, MS
    Flanagan, FL
    Dehdashti, F
    Siegel, BA
    Cooper, JD
    [J]. ANNALS OF THORACIC SURGERY, 1997, 64 (03) : 770 - 776
  • [5] Buenaventura P, 2000, Chest Surg Clin N Am, V10, P487
  • [6] The role of type of tobacco and type of alcoholic beverage in oral carcinogenesis
    Castellsagué, X
    Quintana, MJ
    Martínez, MC
    Nieto, A
    Sánchez, MJ
    Juan, A
    Monner, A
    Carrera, M
    Agudo, A
    Quer, M
    Muñoz, N
    Herrero, R
    Franceschi, S
    Bosch, FX
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (05) : 741 - 749
  • [7] Chandawarkar RY, 1996, J SURG ONCOL, V61, P214, DOI 10.1002/(SICI)1096-9098(199603)61:3<214::AID-JSO10>3.0.CO
  • [8] 2-7
  • [9] Contribution of the PET-TAC in diagnostic-therapeutic decisions in Medical Oncology
    Cortes-Funes, H.
    [J]. REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2008, 27 (02): : 79 - 82
  • [10] Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma
    Flamen, P
    Lerut, A
    Van Cutsem, E
    De Wever, W
    Peeters, M
    Stroobants, S
    Dupont, P
    Bormans, G
    Hiele, M
    De Leyn, P
    Van Raemdonck, D
    Coosemans, W
    Ectors, N
    Haustermans, K
    Mortelmans, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (18) : 3202 - 3210